Recent trends in the healthcare sector have left some investors holding onto underperforming stocks, notably Medtronic (MDT), Sanofi (SNY), and Bristol Myers Squibb (BMY), which continue to offer attractive dividends despite price declines. Medtronic’s stock has dropped over 35% in five years, yet it maintains a 3.3% dividend yield, backed by consistent revenue growth in its medical device segment. Sanofi, facing challenges with its key drug Dupixent and leadership changes, offers a 5% yield while navigating a crucial pipeline transition. Meanwhile, Bristol Myers has seen its stock dip around 10% over five years, but its growth portfolio is gaining traction, and it pays a 4.2% dividend.
For market professionals, the resilience of these dividends amidst stock price volatility highlights a strategic opportunity. Investors may find value in these companies as they await potential recoveries, especially with Bristol Myers showing promising growth momentum. The dividends provide a cushion while shareholders monitor the evolving landscape of healthcare stocks.
Source: fool.com